Unknown

Dataset Information

0

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice.


ABSTRACT: As COVID-19 continues to spread rapidly worldwide and variants continue to emerge, the development and deployment of safe and effective vaccines are urgently needed. Here, we developed an mRNA vaccine based on the trimeric receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein fused to ferritin-formed nanoparticles (TF-RBD). Compared to the trimeric form of the RBD mRNA vaccine (T-RBD), TF-RBD delivered intramuscularly elicited robust and durable humoral immunity as well as a Th1-biased cellular response. After further challenge with live SARS-CoV-2, immunization with a two-shot low-dose regimen of TF-RBD provided adequate protection in hACE2-transduced mice. In addition, the mRNA template of TF-RBD was easily and quickly engineered into a variant vaccine to address SARS-CoV-2 mutations. The TF-RBD multivalent vaccine produced broad-spectrum neutralizing antibodies against Alpha (B.1.1.7) and Beta (B.1.351) variants. This mRNA vaccine based on the encoded self-assembled nanoparticle-based trimer RBD provides a reference for the design of mRNA vaccines targeting SARS-CoV-2.

SUBMITTER: Sun W 

PROVIDER: S-EPMC8426336 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice.

Sun Wenqiang W   He Lihong L   Zhang He H   Tian Xiaodong X   Bai Zhihua Z   Sun Lei L   Yang Limin L   Jia Xiaojuan X   Bi Yuhai Y   Luo Tingrong T   Cheng Gong G   Fan Wenhui W   Liu Wenjun W   Li Jing J  

Signal transduction and targeted therapy 20210909 1


As COVID-19 continues to spread rapidly worldwide and variants continue to emerge, the development and deployment of safe and effective vaccines are urgently needed. Here, we developed an mRNA vaccine based on the trimeric receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein fused to ferritin-formed nanoparticles (TF-RBD). Compared to the trimeric form of the RBD mRNA vaccine (T-RBD), TF-RBD delivered intramuscularly elicited robust and durable humoral immunity as well as a Th1-bias  ...[more]

Similar Datasets

| S-EPMC9197463 | biostudies-literature
| S-EPMC11561850 | biostudies-literature
| S-EPMC11497263 | biostudies-literature
| S-EPMC9482656 | biostudies-literature
| S-EPMC9299372 | biostudies-literature
2024-05-12 | GSE240940 | GEO
| S-EPMC11852987 | biostudies-literature
| S-EPMC10199074 | biostudies-literature
| S-EPMC8915453 | biostudies-literature
| S-EPMC11563480 | biostudies-literature